| 000 | 01528 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250513035628.0 | ||
| 264 | 0 | _c19951012 | |
| 008 | 199510s 0 0 fre d | ||
| 022 | _a0929-693X | ||
| 024 | 7 |
_a10.1016/0929-693x(96)81226-7 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHodson, M | |
| 245 | 0 | 0 |
_a[Multicenter study of rhDNase in cystic fibrosis with severe pulmonary involvement]. _h[electronic resource] |
| 260 |
_bArchives de pediatrie : organe officiel de la Societe francaise de pediatrie _cJul 1995 |
||
| 300 |
_a679-81 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; English Abstract; Journal Article; Multicenter Study; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdministration, Inhalation |
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 |
_aCystic Fibrosis _xdrug therapy |
| 650 | 0 | 4 |
_aDeoxyribonuclease I _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 |
_aExpectorants _xadministration & dosage |
| 650 | 0 | 4 |
_aForced Expiratory Volume _xdrug effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLung _xphysiopathology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aRecombinant Proteins _xadministration & dosage |
| 650 | 0 | 4 | _aRheology |
| 650 | 0 | 4 |
_aVital Capacity _xdrug effects |
| 773 | 0 |
_tArchives de pediatrie : organe officiel de la Societe francaise de pediatrie _gvol. 2 _gno. 7 _gp. 679-81 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0929-693x(96)81226-7 _zAvailable from publisher's website |
| 999 |
_c7663091 _d7663091 |
||